Cabasag, Marites .
HRN: 15-85-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
METRONIDAZOLE 500MG (TAB)
07/06/2022
07/12/2022
PO
500mg
TID
S/P NSVD With Episiotomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes